These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 27493446)
1. Discovery and Validation of Hypermethylated Markers for Colorectal Cancer. Wei J; Li G; Dang S; Zhou Y; Zeng K; Liu M Dis Markers; 2016; 2016():2192853. PubMed ID: 27493446 [TBL] [Abstract][Full Text] [Related]
2. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma. Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013 [TBL] [Abstract][Full Text] [Related]
3. Identification of novel DNA methylation markers in colorectal cancer using MIRA-based microarrays. Li H; Du Y; Zhang D; Wang LN; Yang C; Liu B; Wang WJ; Shi L; Hong WG; Zhang L; Yang YX Oncol Rep; 2012 Jul; 28(1):99-104. PubMed ID: 22552777 [TBL] [Abstract][Full Text] [Related]
4. A DNA methylation panel for high performance detection of colorectal cancer. Jamialahmadi K; Azghandi M; Javadmanesh A; Zardadi M; Shams Davodly E; Kerachian MA Cancer Genet; 2021 Apr; 252-253():64-72. PubMed ID: 33387936 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker. Ravegnini G; Zolezzi Moraga JM; Maffei F; Musti M; Zenesini C; Simeon V; Sammarini G; Festi D; Hrelia P; Angelini S Int J Mol Sci; 2015 Dec; 16(12):28486-97. PubMed ID: 26633373 [TBL] [Abstract][Full Text] [Related]
6. Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancer. Shavali M; Moradi A; Tahmaseb M; Mohammadian K; Ganji SM BMC Med Genomics; 2024 Apr; 17(1):117. PubMed ID: 38689296 [TBL] [Abstract][Full Text] [Related]
7. Serum methylation levels of TAC1. SEPT9 and EYA4 as diagnostic markers for early colorectal cancers: a pilot study. Liu Y; Tham CK; Ong SY; Ho KS; Lim JF; Chew MH; Lim CK; Zhao Y; Tang CL; Eu KW Biomarkers; 2013 Aug; 18(5):399-405. PubMed ID: 23862763 [TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer. Roperch JP; Incitti R; Forbin S; Bard F; Mansour H; Mesli F; Baumgaertner I; Brunetti F; Sobhani I BMC Cancer; 2013 Dec; 13():566. PubMed ID: 24289328 [TBL] [Abstract][Full Text] [Related]
9. Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer. Tham C; Chew M; Soong R; Lim J; Ang M; Tang C; Zhao Y; Ong SY; Liu Y Cancer; 2014 Oct; 120(20):3131-41. PubMed ID: 24925595 [TBL] [Abstract][Full Text] [Related]
10. Genes CEP55, FOXD3, FOXF2, GNAO1, GRIA4, and KCNA5 as potential diagnostic biomarkers in colorectal cancer. Hauptman N; Jevšinek Skok D; Spasovska E; Boštjančič E; Glavač D BMC Med Genomics; 2019 Apr; 12(1):54. PubMed ID: 30987631 [TBL] [Abstract][Full Text] [Related]
11. Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA. Tóth K; Wasserkort R; Sipos F; Kalmár A; Wichmann B; Leiszter K; Valcz G; Juhász M; Miheller P; Patai ÁV; Tulassay Z; Molnár B PLoS One; 2014; 9(12):e115415. PubMed ID: 25526039 [TBL] [Abstract][Full Text] [Related]
12. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array. Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652 [TBL] [Abstract][Full Text] [Related]
13. Hypermethylated DNA, a circulating biomarker for colorectal cancer detection. Rasmussen SL; Krarup HB; Sunesen KG; Johansen MB; Stender MT; Pedersen IS; Madsen PH; Thorlacius-Ussing O PLoS One; 2017; 12(7):e0180809. PubMed ID: 28700744 [TBL] [Abstract][Full Text] [Related]
15. Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions. Tänzer M; Balluff B; Distler J; Hale K; Leodolter A; Röcken C; Molnar B; Schmid R; Lofton-Day C; Schuster T; Ebert MP PLoS One; 2010 Feb; 5(2):e9061. PubMed ID: 20140221 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic Assessment of septin9 DNA Methylation for Colorectal Cancer Using Blood Detection: A Meta-Analysis. Sun G; Meng J; Duan H; Zhang D; Tang Y Pathol Oncol Res; 2019 Oct; 25(4):1525-1534. PubMed ID: 30488278 [TBL] [Abstract][Full Text] [Related]
17. Performance of a Novel Blood-Based Early Colorectal Cancer Screening Assay in Remaining Serum after the Blood Biochemical Test. Chen Y; Wang Z; Zhao G; Sun C; Ma Y; Zhang L; Zheng M; Li H Dis Markers; 2019; 2019():5232780. PubMed ID: 31089394 [TBL] [Abstract][Full Text] [Related]
18. Circadian Rhythm of Methylated Septin 9, Cell-Free DNA Amount and Tumor Markers in Colorectal Cancer Patients. Tóth K; Patai ÁV; Kalmár A; Barták BK; Nagy ZB; Galamb O; Wichmann B; Tulassay Z; Molnár B Pathol Oncol Res; 2017 Jul; 23(3):699-706. PubMed ID: 28035516 [TBL] [Abstract][Full Text] [Related]
19. DNA methylation of CMTM3, SSTR2, and MDFI genes in colorectal cancer. Li J; Chen C; Bi X; Zhou C; Huang T; Ni C; Yang P; Chen S; Ye M; Duan S Gene; 2017 Sep; 630():1-7. PubMed ID: 28782576 [TBL] [Abstract][Full Text] [Related]
20. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer. McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]